Bellerophon is a clinical-stage biotherapeutics firm that researches and commercializes novel therapies for the treatment of cardiac diseases... Read more
Bellerophon is a clinical-stage biotherapeutics firm that researches and commercializes novel therapies for the treatment of cardiac diseases... Read more
News
Dec 01, 2023
Owler
Bellerophon Therapeutics, Inc.: Bellerophon Therapeutics's revenue had no change from Jun 2023 to Sep 2023
Nov 28, 2023
Citybizlist
Bellerophon Therapeutics: Hilco Streambank to Acquire Bellerophon
Oct 16, 2023
Endpoints News
Bellerophon Therapeutics: Bellerophon Therapeutics meets its end after board approves liquidation
Aug 15, 2023
Owler
Bellerophon Therapeutics, Inc.: Bellerophon Therapeutics's revenue had no change from Mar 2023 to Jun 2023
Jun 30, 2023
Endpoints News
Bellerophon Therapeutics: Bellerophon Therapeutics lets almost all employees go, looks for deals in wake of PhIII flop
Jun 29, 2023
MarketScreener
Bellerophon Therapeutics: Bellerophon Therapeutics : Costs Associated with Exit/Disposal - Form 8-K
Jun 05, 2023
MarketScreener
Bellerophon Therapeutics: Bellerophon Therapeutics : Conference Call Presentation
Jun 05, 2023
Endpoints News
Bellerophon Therapeutics: Bellerophon Therapeutics' drug-device fails another PhIII in lung disease, stock implodes
Jun 05, 2023
LD Micro
Press Release: Bellerophon Therapeutics : Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse for Treatment of Fibrotic Interstitial Lung Disease
Jun 05, 2023
MarketWatch
Bellerophon Therapeutics: : Bellerphon Therapeutics stock plunges toward record selloff after lung disease treatment performs worse than placebo in late-stage trial
Bellerophon Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10